Dechra has launched Felimazole Oral Solution 5mg/ml (thiamazole) for the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy and for the long-term treatment of feline hyperthyroidism.

The new presentation is honey-flavoured and is available in 30ml or 100ml bottles with a syringe for precise dosing. 

It has a two-year shelf life and a broached shelf life of six months. 

Dechra companion animal brand manager, Thomas Johnson, said: “The addition of Felimazole Oral to our product range will provide vets with the flexibility to prescribe Felimazole as either a tablet or oral solution to accommodate the preferences of both the cat and its owner. 

"This, combined with our extensive endocrinology resources, will ensure that vets have all the necessary tools to support their feline hyperthyroid cases.”

https://www.dechra.co.uk/cushings-connect 

https://www.dechra.co.uk/addisons-connect 

https://www.dechra.co.uk/search?q=felimazole#/search=Felimazole 

https://apps.apple.com/gb/app/dechra-endocrinology-app/id1660737534

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.